Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Western Hunter-Gatherer genetic ancestry contributes to human longevity in the Italian population.

GeroScience·2025
Same author

Inflammaging and the sex-frailty paradox.

Aging clinical and experimental research·2025
Same author

The Genetic Puzzle of the Stress-Induced Cardiomyopathy (Takotsubo Syndrome): State of Art and Future Perspectives.

Biomolecules·2025
Same author

YY1 mutations disrupt corticogenesis through a cell type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs.

Molecular psychiatry·2025
Same author

Diagnostic Accuracy of Lipid Transfer Proteins (LTPs) Specific IgE Assay in Food Allergy: A Systematic Review.

International journal of molecular sciences·2024
Same author

Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single-cell resolution.

Nature methods·2024
Same journal

Retraction Note: Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations.

Immunity & ageing : I & A·2026
Same journal

Longitudinal humoral and memory B-cell responses to repeated SARS-CoV-2 vaccination in long-term care facilities residents.

Immunity & ageing : I & A·2026
Same journal

Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.

Immunity & ageing : I & A·2026
Same journal

An immune-associated mitochondrial DNA variant with sex differences reveals a putative novel microprotein called MASL.

Immunity & ageing : I & A·2026
Same journal

Immune risk phenotype and long-term mortality after community-acquired pneumonia in older adults: clinical and immune determinants.

Immunity & ageing : I & A·2026
Same journal

Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adults.

Immunity & ageing : I & A·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Hemostasis and ageing.

Daniela Mari1, Giulia Ogliari, Davide Castaldi

  • 1Dipartimento di Scienze Mediche e U.O. di Geriatria, IRCCS, Istituto Auxologico Italiano, UniversitĂ  di Milano, Milano, Italy. daniela.mari@unimi.it

Immunity & Ageing : I & A
|October 25, 2008
PubMed
Summary
This summary is machine-generated.

Physiological aging impairs blood clot breakdown, increasing vascular risks. However, centenarians show hypercoagulability, suggesting aging

More Related Videos

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

Related Experiment Videos

Last Updated: Jun 28, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

Area of Science:

  • Gerontology
  • Vascular Biology
  • Hematology

Background:

  • Physiological aging is linked to altered blood coagulation and fibrinolysis.
  • Age-related changes in hemostasis may increase risks for vascular and thromboembolic diseases.
  • The hemostatic profile of centenarians presents a paradox of hypercoagulability and longevity.

Purpose of the Study:

  • To summarize the lecture on hemostasis and aging presented at a symposium.
  • To discuss the implications of hemostatic changes in aging populations.
  • To explore the relationship between hypercoagulability, atherothrombotic markers, and health in centenarians.

Main Methods:

  • Review of a lecture on hemostasis and aging.
  • Discussion of physiological changes in blood coagulation and fibrinolysis with age.
  • Analysis of hemostatic markers in centenarians in relation to longevity and health.

Main Results:

  • Aging is associated with increased plasma coagulation proteins and impaired fibrinolysis.
  • Centenarians exhibit hypercoagulability and atherothrombotic risk markers, yet maintain longevity and health.
  • Traditional cardiovascular risk factors may have diminished significance in advanced age.

Conclusions:

  • Hemostatic system alterations during aging require careful consideration for vascular health.
  • Centenarian data suggest a complex interplay between hypercoagulability, aging, and health outcomes.
  • The biological significance of atherothrombotic risk factors may change with advanced age.